Kyle Truitt, Co-Founder, Turning Point, LLC, speaks about how pharmaceutical manufacturers can benefit from the launch of the High-Performing Specialty Pharmacy Association.
Specialty Pharmacy
Advertisement
Collecting data that show the most efficient and effective ways to clinically manage patients is becoming more important than ever in specialty pharmacy.
Advertisement
Gene-editing technology may be more effective reducing cardiovascular risks than targeting PCSK9.
A newer drug may preserve quality of life better than chemotherapy for patients with renal cell carcinoma.
Top news of the day from across the health care landscape.
The Approved Drug Products with Therapeutic Equivalence Evaluations is commonly known as the Orange Book.
Advertisement
Officials with the FDA have approved Medtronic’s continuous glucose monitoring (CGM) system (Guardian Connect) for use by individuals living with diabetes, according to a company press release.
Payers may achieve an additional discount for alirocumab (Praluent) if they agree to value-based contracts.
A gene mutation linked to chordoid gliomas may result in targeted treatment options.
Findings suggest that incomplete transcription causes latency in HIV infected cells.
Advertisement
Top news of the day from across the health care landscape.
Olaparib (Lynparza) double objective response rate compared with other breast cancer drugs.
Targeted administration of chemotherapy and immunotherapy may improve treatment of low-immunogenic tumors.
Ron Lanton III, Esq., President, True North Political Solutions, speaks about proposed legislation that could bolster the emergence of biosimilars.
Intake of fish high in omega-3 fatty acids could help reduce the risk of developing multiple sclerosis or clinically isolated syndrome.
A strain of Staphylococcus epidermidis may be able to reduce skin cancer growth.
Top news of the day from across the health care landscape.
Many patients with HIV develop neurocognitive disorders, which is incurable.
Top news of the week from The American Journal of Pharmacy Benefits.
A combination therapy that attacks the viral reservoir may be crucial to controlling HIV replication without medication.
This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.
Pharmacists are medication experts who play an integral role in the health care team. I am honored to be a pharmacist and believe that we are lifelong learners.
Top news of the week from Specialty Pharmacy Times.
Top news of the day from across the health care landscape.
John Giannouris, vice president, Specialty Pharmacy Services, ValueCentric, speaks about how specialty pharmacies and other stakeholders can harness patient data to improve outcomes.
Basic Care's products are cheaper to buy in bulk compared with other store brands.
Cigna to acquire major pharmacy benefit manager for $67 billion.
New research may overcome hurdles to eliminating viral reservoirs that prevent curing HIV.
Patients between 18 and 24 years of age with IBD may have a greater risk of heart attacks.
Malignant peripheral nerve sheath tumors are currently incurable.
Advertisement
Advertisement
Trending on Pharmacy Times
1
A Review of Antibody-Drug Conjugates for the Treatment of Urothelial Carcinoma: The Rise of Enfortumab Vedotin
2
Oral Semaglutide Shows Promise for Weight Loss and Cardiometabolic Health
3
MFN, DTC, and the Policy Pressure Cooker: Reshaping the US Drug Market
4
Interim Phase 2 IOV-LUNG-202 Data Show Lifileucel’s Potential Treating Advanced NSCLC
5
